Mabthera

196,64 252,10 

Therapeutic CD20-antibody from the original Mabthera commercial drug targeting the CD20-antigen, also referred to as Mabthera antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Manufacturing Year PriceQuantityTotal
aliquot 102002H0203B052015 196,64 
-
+
196,64 
spinner
aliquot 102002H0209B042016 196,64 
-
+
196,64 
spinner
aliquot 102002N7129B162016 196,64 
-
+
196,64 
spinner
aliquot 102002N7135B182016 196,64 
-
+
196,64 
spinner
aliquot 102002N7135B112016 196,64 
-
+
196,64 
spinner
aliquot 102002N7174B062017 196,64 
-
+
196,64 
spinner
aliquot 102002N7190B082017 196,64 
-
+
196,64 
spinner
dilution11000,1-- 252,10 
-
+
252,10 
spinner

Category: SKU: N/A

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Rituximab

Antigen

CD20

Product Concentration [mg/mL]

1, 10

Volume per Vial [µL]

100, 200

Quantity per vial [mg]

0, 0,1, 2

Batch Number

NOT APPLICABLE, H0209B04, N7129B16, N7135B18, N7174B06, N7190B08, -, H0203B05, N7135B11

Manufacturing Year

-, 2015, 2016, 2017